Effectiveness of Single vs Multiple Doses of Prophylactic Intravenous Antibiotics in Implant-Based Breast Reconstruction

  17 September 2022

Do rates of postoperative surgical site infections after implant-based breast reconstruction improve when using a multiple-dose instead of a single-dose prophylactic antibiotic regimen?

In this randomized clinical trial, there were no differences in rates of postoperative infections among patients managed with single vs multiple doses of prophylactic antibiotics; multiple doses were associated with higher rates of adverse events.

Multiple-dose intravenous antibiotic prophylaxis is not superior to a single-dose regimen in preventing postoperative infection after implant-based breast reconstruction and is not recommended because of the associated higher rates of adverse events.

Further reading: JAMA Network Open
Author(s): Jessica Gahm et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!